ReviewTicks and tick-borne diseases2026
Why are the ticks winning, and what can we do about it?
Review in Ticks and tick-borne diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The ecology of Lyme disease: Long-term data, surprises, and a synthesis.Proceedings of the National Academy of Sciences of the United States of America · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
Human illness associated with tick bites is on the rise in the United States. One root cause is that several human-biting tick species serving as pathogen vectors, including the blacklegged tick and the lone star tick, have expanded their geographic ranges in recent decades, with many areas in the U.S. now harboring multiple species of vector ticks. As currently used, personal tick bite prevention and environmental tick control have not succeeded in stemming the rising tide of humans being bitten by ticks. A national strategy to prevent and control vector-borne diseases provides a blueprint to solve the problem, but this will require sustained investments in tick bite prevention and tick control. Efforts are needed to: (i) stimulate industry engagement in development of novel technologies and products; (ii) intensify research to clarify the benefit of using different tick bite prevention and tick control methods, and clarify barriers to their adoption and use; (iii) establish publicly-funded local organizational structures to support individuals and communities in their efforts to prevent tick bites; and (iv) strengthen the workforce in public health, academia, and industry with expertise in ticks and tick-borne diseases. Solving the problem with ticks in the U.S. will be challenging but is worth pursuing because the alternative is for the public to accept that illness associated with tick bites now is simply a fact of life and that the problem is likely to get worse over time. This perspective paper includes "take home messages" and a conclusions section for an abbreviated read.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.